Alzheimer's disease steals memories and devastates lives. Yet despite an abundance of research, the earliest brain changes ...

A loss of smell can be one of the earliest warning signs of Alzheimer’s disease, but the reasons behind this sensory change ...

For nearly a decade, scientists from Harvard University have also been uncovering lithium’s unexpected importance in the brain ...

Treatment with IV donanemab in early-stage Alzheimer’s disease demonstrated sustained clinical benefits for up to 3 years, with early initiation responsible for better outcomes, data from a long-term ...

New research shows that people with dementia experience faster memory decline if they’re also diagnosed with inflammatory bowel disease (IBD).

Blood-based biomarker testing may aid in diagnosing Alzheimer disease (AD) in specialized care settings, according to a newly published Alzheimer’s Association Clinical Practice Guideline in Alzheimer ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the availability of the Lumipulse® pTau-217/Beta Amyloid 42 Ratio, the first blood-based ...

Labcorp has launched the first blood-based in-vitro diagnostic test cleared by the Food and Drug Administration to aid in the diagnosis of Alzheimer's disease.

The treatment eliminates harmful protein buildup linked to Alzheimer’s disease. Scientists at the, Irvine, have uncovered a potential non-drug approach that revitalizes aging brain cells and removes ...

Compared with other antidiabetic drugs, semaglutide is associated with a lower risk for Alzheimer disease-related dementia in patients with type 2 diabetes.

The Ontario Provincial Police (OPP) is urging families, caregivers, and communities to take proactive steps to protect ...

The influence of B vitamins on cognitive function, heart health, cancer and even gastric bypass recovery has been highlighted ...